- Novo Nordisk continues to slip after outlook cut, obesity drug worries (NVO:NYSE) Seeking Alpha
- Wegovy maker Novo’s profit warning triggers $70 billion share rout Reuters
- Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times
- NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead? Yahoo Finance
- Health Care Roundup: Market Talk The Wall Street Journal
Source link